Baseline characteristics of NHL patients and matched comparators for the risk of diabetes mellitus analysis
| . | NHL patients (n = 5175) . | Comparators (n = 25 875) . |
|---|---|---|
| Male | 2875 (55.56%) | 14 375 (55.56%) |
| Median age (IQR) | 65 (17) | 65 (17) |
| CVD | 721 (13.93%) | 4055 (15.67%) |
| Cerebrovacular disease | 218 (4.21%) | 1552 (6.00%) |
| Circulatory disease | 1418 (27.40%) | 7661 (29.61%) |
| Chronic obstructive pulmonary disease | 192 (3.71%) | 1289 (4.98%) |
| Liver disease | 62 (1.20%) | 352 (1.36%) |
| Renal disease | 115 (2.22%) | 599 (2.31%) |
| Higher education | 3048 (60.86%) | 14 999 (60.75%) |
| Missing | 167 | 1184 |
| Performance score | ||
| 0 | 2925 (56.52%) | |
| 1 | 1602 (30.96%) | |
| 2 | 379 (7.32%) | |
| 3 | 195 (3.77%) | |
| 4 | 74 (1.43%) | |
| Ann Arbor stage | ||
| 1 | 854 (16.69%) | |
| 2 | 767 (14.99%) | |
| 3 | 1137 (22.22%) | |
| 4 | 2359 (46.10%) | |
| Missing | 58 | |
| Treatment | ||
| R-CVP | 917 (17.72%) | |
| R-CHOP(-like) | 4258 (82.28%) | |
| . | NHL patients (n = 5175) . | Comparators (n = 25 875) . |
|---|---|---|
| Male | 2875 (55.56%) | 14 375 (55.56%) |
| Median age (IQR) | 65 (17) | 65 (17) |
| CVD | 721 (13.93%) | 4055 (15.67%) |
| Cerebrovacular disease | 218 (4.21%) | 1552 (6.00%) |
| Circulatory disease | 1418 (27.40%) | 7661 (29.61%) |
| Chronic obstructive pulmonary disease | 192 (3.71%) | 1289 (4.98%) |
| Liver disease | 62 (1.20%) | 352 (1.36%) |
| Renal disease | 115 (2.22%) | 599 (2.31%) |
| Higher education | 3048 (60.86%) | 14 999 (60.75%) |
| Missing | 167 | 1184 |
| Performance score | ||
| 0 | 2925 (56.52%) | |
| 1 | 1602 (30.96%) | |
| 2 | 379 (7.32%) | |
| 3 | 195 (3.77%) | |
| 4 | 74 (1.43%) | |
| Ann Arbor stage | ||
| 1 | 854 (16.69%) | |
| 2 | 767 (14.99%) | |
| 3 | 1137 (22.22%) | |
| 4 | 2359 (46.10%) | |
| Missing | 58 | |
| Treatment | ||
| R-CVP | 917 (17.72%) | |
| R-CHOP(-like) | 4258 (82.28%) | |
IQR, interquartile range.